|
US6130206A
(en)
*
|
1980-07-07 |
2000-10-10 |
Hem Research, Inc. |
Treating viral infections associated with chronic fatigue with dsRNA
|
|
US9309574B1
(en)
|
1984-08-22 |
2016-04-12 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Molecular cloning of HIV-1 from immortalized cell lines
|
|
US5906980A
(en)
*
|
1987-07-17 |
1999-05-25 |
Hem Research Inc. |
Treatment of hepatitis with mismatched dsRNA
|
|
US5091374A
(en)
*
|
1987-07-17 |
1992-02-25 |
Hem Research Inc. |
Double-stranded RNA correction of abnormalities in circulating immune complexes and monocyte function
|
|
US5712257A
(en)
*
|
1987-08-12 |
1998-01-27 |
Hem Research, Inc. |
Topically active compositions of mismatched dsRNAs
|
|
US4963532A
(en)
*
|
1987-11-25 |
1990-10-16 |
Hem Research, Inc. |
dsRNA-based prevention of viral escape
|
|
US4960592A
(en)
*
|
1989-04-17 |
1990-10-02 |
Lanocare Laboratories |
Lanolin and lanolin oil skin treatment composition
|
|
US5132292A
(en)
*
|
1990-05-25 |
1992-07-21 |
Hem Research, Inc. |
Treatment of viral hepatitis
|
|
US5614504A
(en)
*
|
1990-08-01 |
1997-03-25 |
The University Of South Florida |
Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
|
|
US6703418B2
(en)
*
|
1991-02-26 |
2004-03-09 |
Unimed Pharmaceuticals, Inc. |
Appetite stimulation and induction of weight gain in patients suffering from symptomatic HIV infection
|
|
CA2102221A1
(en)
*
|
1991-04-16 |
1992-10-17 |
William Carter |
Abrogation of viral resistance to nucleoside analogues by double-stranded rnas
|
|
GB9108085D0
(en)
*
|
1991-04-16 |
1991-06-05 |
Scras |
Complexes of polyadenylic acid with polyuridylic acid
|
|
CA2113573A1
(en)
*
|
1991-07-16 |
1993-02-04 |
William Carter |
Modulation and diagnosis of cytokine dysfunctions
|
|
US20030207813A1
(en)
*
|
1996-12-09 |
2003-11-06 |
G.D. Searle |
Retroviral protease inhibitor combinations
|
|
US5766582A
(en)
*
|
1994-10-11 |
1998-06-16 |
Schering Corporation |
Stable, aqueous alfa interferon solution formulations
|
|
CN1192688A
(zh)
*
|
1995-06-07 |
1998-09-09 |
特莱默里斯公司 |
联合疗法治疗hiv和其它病毒性感染
|
|
US5834443A
(en)
*
|
1996-05-21 |
1998-11-10 |
Masiello; Domenick J. |
Composition and method for treating herpes simplex
|
|
RU2123339C1
(ru)
*
|
1996-06-18 |
1998-12-20 |
Государственный научный центр вирусологии и биотехнологии "Вектор" |
Противовирусное средство
|
|
CA2278158A1
(en)
*
|
1997-01-14 |
1998-07-16 |
Guangyi Wang |
Cytokine related treatments of disease
|
|
GB9622681D0
(en)
*
|
1996-10-31 |
1997-01-08 |
Glaxo Group Ltd |
Pharmaceutical compositions
|
|
LT4475B
(lt)
*
|
1997-02-28 |
1999-02-25 |
Virmantas Stunžėnas |
Informacinės ribonukleino rūgšties panaudojimas vaistinėse medžiagose, skirtose padidinti šios ribonukleino rūgšties koduojamo baltymo kiekį paciento ląstelėse
|
|
FR2768345B1
(fr)
*
|
1997-09-17 |
2001-05-04 |
Scras |
Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale, notamment d'une hepatite virale
|
|
FR2766715B1
(fr)
*
|
1997-08-04 |
2001-02-16 |
Scras |
Produit comprenant au moins de l'arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique simultanee, separee ou etalee dans le temps, dans le traitement d'une maladie virale
|
|
FR2768344B1
(fr)
*
|
1997-08-26 |
2001-02-16 |
Scras |
Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale
|
|
AR013269A1
(es)
*
|
1997-08-04 |
2000-12-13 |
Scras |
Producto que contiene por lo menos un rna de doble filamento combinado con por lo menos un agente anti-viral, para la utilizacion terapeutica en eltratamiento de una enfermedad viral, en especial de la hepatitis viral
|
|
FR2766711B1
(fr)
*
|
1997-08-04 |
2001-02-02 |
Sod Conseils Rech Applic |
Produit comprenant au moins un arn double brin en association avec au moins un devire du 6-benzyluracile pour une utilisation therapeutique simultanee, separee ou etalee dans le temps
|
|
US6506559B1
(en)
*
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
|
ES2374290T3
(es)
|
1998-03-20 |
2012-02-15 |
Commonwealth Scientific And Industrial Research Organisation |
Genes sintéticos y constructos genéticos que comprenden los mismos.
|
|
AUPP249298A0
(en)
|
1998-03-20 |
1998-04-23 |
Ag-Gene Australia Limited |
Synthetic genes and genetic constructs comprising same I
|
|
FR2776927B1
(fr)
*
|
1998-04-07 |
2002-07-05 |
Univ Paris Curie |
Compositions pour la vectorisation de molecules
|
|
CA2361201A1
(en)
|
1999-01-28 |
2000-08-03 |
Medical College Of Georgia Research Institute, Inc. |
Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
|
|
US6977245B2
(en)
|
1999-04-12 |
2005-12-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
|
US6423885B1
(en)
|
1999-08-13 |
2002-07-23 |
Commonwealth Scientific And Industrial Research Organization (Csiro) |
Methods for obtaining modified phenotypes in plant cells
|
|
RU2172631C2
(ru)
*
|
1999-10-08 |
2001-08-27 |
Государственный научный центр вирусологии и биотехнологии "Вектор" |
Индуктор интерферона пролонгированного действия
|
|
EP1322655B1
(en)
|
2000-01-14 |
2007-11-14 |
The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
|
US7638496B2
(en)
|
2000-02-15 |
2009-12-29 |
Valeant Pharmaceuticals North America |
Nucleoside analogs with carboxamidine modified monocyclic base
|
|
US20080242627A1
(en)
*
|
2000-08-02 |
2008-10-02 |
University Of Southern California |
Novel rna interference methods using dna-rna duplex constructs
|
|
DE10100588A1
(de)
*
|
2001-01-09 |
2002-07-18 |
Ribopharma Ag |
Verfahren zur Hemmung der Expression eines Zielgens
|
|
EP1229134A3
(en)
|
2001-01-31 |
2004-01-28 |
Nucleonics, Inc |
Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
|
|
US7666674B2
(en)
|
2001-07-27 |
2010-02-23 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
|
|
AU2002361468A1
(en)
|
2001-08-14 |
2003-03-18 |
The Government Of The United States Of America As Represented By The Secretary Of Health And Human S |
Method for rapid generation of mature dendritic cells
|
|
CA2470204A1
(en)
*
|
2001-12-14 |
2003-06-26 |
William A. Carter |
Use of dsrnas in strategic therapeutic intervention of highly active antiretroviral therapy
|
|
US8466116B2
(en)
|
2001-12-20 |
2013-06-18 |
The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of CpG oligodeoxynucleotides to induce epithelial cell growth
|
|
WO2003054161A2
(en)
|
2001-12-20 |
2003-07-03 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS
|
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
|
EP1478656B1
(en)
|
2002-02-01 |
2009-09-16 |
Life Technologies Corporation |
Oligonucleotide compositions with enhanced efficiency
|
|
ES2734652T3
(es)
|
2002-04-04 |
2019-12-11 |
Zoetis Belgium S A |
Oligorribonucleótidos inmunoestimulantes que contienen G y U
|
|
US8263091B2
(en)
|
2002-09-18 |
2012-09-11 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides
|
|
US20050137154A1
(en)
*
|
2003-05-16 |
2005-06-23 |
Hemispherx Biopharma |
Treating server acute respiratory syndrome
|
|
US20060035859A1
(en)
*
|
2003-05-16 |
2006-02-16 |
Hemispherx Biopharma |
Treating severe and acute viral infections
|
|
WO2005007831A2
(en)
*
|
2003-07-18 |
2005-01-27 |
Vanderbilt University |
Compositions of protein mimetics and methods of using same against hiv-1, sars-cov and the like
|
|
WO2005014038A1
(ja)
*
|
2003-08-11 |
2005-02-17 |
The Research Foundation For Microbial Diseases Of Osaka University |
粘膜免疫誘導アジュバントを含む新規ワクチン
|
|
RU2272631C2
(ru)
*
|
2004-04-20 |
2006-03-27 |
Государственный научный центр вирусологии и биотехнологии "Вектор" (ГНЦ ВБ "Вектор") |
Синергическая композиция для ингибирования вич
|
|
DE202005004135U1
(de)
*
|
2005-03-11 |
2005-05-19 |
Klocke Verpackungs-Service Gmbh |
Mehrkomponentenverpackung mit Applikator
|
|
EP2883957A1
(en)
|
2005-11-25 |
2015-06-17 |
Zoetis Belgium S.A. |
Immunostimmulatory oligoribonucleotides
|
|
CN101437534A
(zh)
*
|
2006-03-08 |
2009-05-20 |
半球生物制药公司 |
口服干扰素的广谱免疫和抗病毒基因调节作用
|
|
US8075877B2
(en)
|
2006-03-08 |
2011-12-13 |
Hemispherx Biopharma |
Broad spectrum immune and antiviral gene modulation by oral interferon
|
|
US20100285115A1
(en)
*
|
2007-10-29 |
2010-11-11 |
Cipla Limited |
Novel Antiretroviral Combination
|
|
AU2009215128A1
(en)
*
|
2008-02-15 |
2009-08-20 |
Hemispherx Biopharma, Inc. |
Selective agonist of toll-like receptor 3
|